
Ongoing Trials Aim to Advance HER2-Negative Breast Cancer Treatment
The landscape of HER2-negative breast cancer treatment is evolving, with an increasing focus on precision medicine and individualized treatment strategies, according to Dr. Kevin Kalinsky, who added that ongoing clinical trials aim to clarify current …